ACTO Technologies Inc.: federal grants and contributions: 4 agreements; $4.0M value; 3 departments; 4 programs.
Assay record ASY-CA-02DC7YC0NA · Cite as: Assay Systems, “ACTO Technologies Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/acto-technologies-inc/
To pilot and commercialize generative artificial intelligence software and accelerate its global expansion to Europe and Asia-Pacific regions.
ACTO will advance PharmaForce and CxZone to improve training, knowledge access and customer engagement in life sciences, enabling safe, scalable AI and faster time-to-competency.
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
Leveraging content on ACTO's Omnichannel platform, LAICA's suite of AI solutions will deliver a series of technologies: 1. Enterprise Search Solution; 2. Recommendation System; and 3. Targeted Insights, to provide seamless learning and sales enablement experiences.
All grants from Federal Economic Development Agency for Southern Ontario
All grants from Innovation, Science and Economic Development Canada
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.